Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 5
Submit an article Journal homepage
476
Views
14
CrossRef citations to date
0
Altmetric
Reviews

The safety of novel drugs used to treat irritable bowel syndrome

Shilan MozaffariTehran University of Medical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Department of Toxicology and Pharmacology, Tehran, 1417614411, Iran+98 21 [email protected], [email protected]
,
Shekoufeh NikfarTehran University of Medical Sciences, Faculty of Pharmacy, Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran, 1417614411, Iran;Iranian Food and Drug Administration, Ministry of Health and Medical Education, Tehran, 1417614411, Iran
&
Mohammad AbdollahiTehran University of Medical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Department of Toxicology and Pharmacology, Tehran, 1417614411, Iran+98 21 [email protected], [email protected]
Pages 625-638 | Published online: 26 Mar 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Sheyda Ranjbar, Seyed Afshin Seyednejad, Shekoufeh Nikfar, Roja Rahimi & Mohammad Abdollahi. (2019) How can we develop better antispasmodics for irritable bowel syndrome?. Expert Opinion on Drug Discovery 14:6, pages 549-562.
Read now
Athanasios E. Dellis, Shilan Mozaffari, Shekoufeh Nikfar, Athanasios G. Papatsoris & Mohammad Abdollahi. (2019) Is there an appropriate strategy for treating co-morbid irritable bowel syndrome and bladder pain syndrome?. Expert Opinion on Pharmacotherapy 20:4, pages 411-414.
Read now
Pamela J Hornby. (2015) Drug discovery approaches to irritable bowel syndrome. Expert Opinion on Drug Discovery 10:8, pages 809-824.
Read now

Articles from other publishers (11)

Shiqi Zhang, Pinglan Li, Suwon Lee, Yu Wang, Chunming Tan & Nan Shang. (2023) Weizmannia coagulans : an Ideal Probiotic for Gut Health . Food Science and Human Wellness, pages 1-20.
Crossref
Tommaso B. Jannini, Giorgio D. Lorenzo, Emanuela Bianciardi, Cinzia Niolu, Massimiliano Toscano, Giacomo Ciocca, Emmanuele A. Jannini & Alberto Siracusano. (2022) Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs). Current Neuropharmacology 20:4, pages 693-712.
Crossref
Meng Meng, Chen Bai, Bo Wan, Luqing Zhao, Zhe Li, Danyan Li & Shengsheng Zhang. (2021) A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder. BioMed Research International 2021, pages 1-14.
Crossref
Bing Li, Li Liang, Huijie Deng, Jinmin Guo, He Shu & Li Zhang. (2020) Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 11.
Crossref
Agnieszka Kułak-Bejda, Grzegorz Bejda & Napoleon Waszkiewicz. (2017) Antidepressants for irritable bowel syndrome—A systematic review. Pharmacological Reports 69:6, pages 1366-1379.
Crossref
Longtu Chen, Sheikh J. Ilham & Bin Feng. (2017) Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesthesiology and Pain Medicine 7:2.
Crossref
Fan Li, Tao Fu, Wei-Dong Tong, Bao-Hua Liu, Chun-Xue Li, Yu Gao, Jin-Song Wu, Xiang-Feng Wang & An-Ping Zhang. (2016) Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome. Mayo Clinic Proceedings 91:4, pages 456-468.
Crossref
Marta Zielińska, Agata Jarmuż, Maciej Sałaga, Andrzej W. Lipkowski & Jakub Fichna. (2016) Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms. Pharmacological Reports 68:1, pages 32-36.
Crossref
Paula Mosińska. (2015) Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation. World Journal of Gastroenterology 21:24, pages 7436.
Crossref
Tina Didari. (2015) Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology 21:10, pages 3072.
Crossref
. (2014) Lubiprostone. Reactions Weekly 1503:1, pages 27-27.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.